Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNA expression and functions in viral infections.

Transcription·2026
Same author

A newly developed eGFP-traceable recombinant rhesus lymphocryptovirus, a tool to study viral infection and replication <i>in vitro</i> and <i>ex vivo</i>, confirms gp350 as key for viral entry.

Journal of virology·2026
Same author

Inhibition of type I interferon signaling is a conserved function of gamma-herpesvirus-encoded microRNAs.

Journal of virology·2025
Same author

EBV Noncoding RNAs.

Current topics in microbiology and immunology·2025
Same author

Sequence Analysis of microRNAs Encoded by Simian Lymphocryptoviruses.

Viruses·2025
Same author

MicroRNA-focused CRISPR/Cas9 screen identifies miR-142 as a key regulator of Epstein-Barr virus reactivation.

PLoS pathogens·2024

Related Experiment Video

Updated: Jun 9, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K

Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas.

Devin N Fachko1, Bonnie Goff1, Yan Chen1

  • 1Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.

Cancers
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

Epstein-Barr virus BART microRNAs target key genes in B cell lymphomas, impacting differentiation, cell cycle, and apoptosis. This study reveals novel interactions and provides insights into viral pathogenesis in these cancers.

Keywords:
B cell lymphomaBART miRNAsEpstein-Barr virusmicroRNAs

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.2K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

40.2K

Related Experiment Videos

Last Updated: Jun 9, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.2K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

40.2K

Area of Science:

  • Molecular Biology
  • Virology
  • Oncology

Background:

  • MicroRNAs regulate gene expression; their dysregulation is linked to cancer.
  • Epstein-Barr virus (EBV) encodes 22 BamHI A Rightward Transcript (BART) miRNAs, crucial in EBV-associated cancers.
  • BART miRNAs are expressed in most EBV-linked cancers and play a role in viral pathogenesis.

Purpose of the Study:

  • To identify biological targets of BART miRNAs in B cell lymphomas.
  • To compare BART miRNA targets across different EBV-positive B cell malignancies.
  • To understand the functional roles of BART miRNAs in B cell cancers.

Main Methods:

  • Meta-analysis of publicly available Ago-CLIP datasets from EBV-positive Burkitt lymphomas (BLs), primary effusion lymphomas (PELs), and AIDS-associated diffuse large B cell lymphomas (DLBCLs).
  • Reporter assays to experimentally validate interactions between BART miRNAs and cellular transcripts.
  • Ectopic BART miRNA expression in EBV-negative BL cells to assess transcriptional changes.

Main Results:

  • Over 50 functional interactions between BART miRNAs and cellular transcripts were validated.
  • Identified targets are involved in B cell differentiation (e.g., PRDM1, IRF4, MYC), cell cycle regulation (e.g., UHMK1, CDKN1A), apoptosis (e.g., MCL1), signaling, and tumor suppression (e.g., CCDC6).
  • Ectopic BART miRNA expression induced transcriptional alterations in EBV-negative BL cells.

Conclusions:

  • This study reveals novel, functional interactions for BART miRNAs in B cell lymphomas.
  • Findings offer insights into the roles of BART miRNAs in the pathogenesis of EBV-associated B cell cancers.
  • The identified miRNA-target interactions provide a basis for further research into therapeutic strategies.